|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
 |
|
|
 |
 |
 |
 |
Enzyme class 1:
|
 |
Chains A, B:
E.C.2.5.1.58
- protein farnesyltransferase.
|
|
 |
 |
 |
 |
 |
Reaction:
|
 |
L-cysteinyl-[protein] + (2E,6E)-farnesyl diphosphate = S-(2E,6E)- farnesyl-L-cysteinyl-[protein] + diphosphate
|
 |
 |
 |
 |
 |
L-cysteinyl-[protein]
Bound ligand (Het Group name = )
corresponds exactly
|
+
|
(2E,6E)-farnesyl diphosphate
|
=
|
S-(2E,6E)- farnesyl-L-cysteinyl-[protein]
|
+
|
diphosphate
|
|
 |
 |
 |
 |
 |
 |
 |
 |
Cofactor:
|
 |
Mg(2+); Zn(2+)
|
 |
 |
 |
 |
 |
Enzyme class 2:
|
 |
Chain A:
E.C.2.5.1.59
- protein geranylgeranyltransferase type I.
|
|
 |
 |
 |
 |
 |
Reaction:
|
 |
geranylgeranyl diphosphate + L-cysteinyl-[protein] = S-geranylgeranyl-L- cysteinyl-[protein] + diphosphate
|
 |
 |
 |
 |
 |
geranylgeranyl diphosphate
Bound ligand (Het Group name = )
matches with 82.76% similarity
|
+
|
L-cysteinyl-[protein]
|
=
|
S-geranylgeranyl-L- cysteinyl-[protein]
|
+
|
diphosphate
|
|
 |
 |
 |
 |
 |
 |
 |
 |
Cofactor:
|
 |
Zn(2+)
|
 |
 |
 |
 |
 |
 |
 |
|
Note, where more than one E.C. class is given (as above), each may
correspond to a different protein domain or, in the case of polyprotein
precursors, to a different mature protein.
|
|
 |
|
Molecule diagrams generated from .mol files obtained from the
KEGG ftp site
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
|
| |
|
DOI no:
|
Biochemistry
37:9612-9618
(1998)
|
|
PubMed id:
|
|
|
|
|
| |
|
Cocrystal structure of protein farnesyltransferase complexed with a farnesyl diphosphate substrate.
|
|
S.B.Long,
P.J.Casey,
L.S.Beese.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
Protein farnesyltransferase (FTase) catalyzes the transfer of the hydrophobic
farnesyl group from farnesyl diphosphate (FPP) to cellular proteins such as Ras
at a cysteine residue near their carboxy-terminus. This process is necessary for
the subcellular localization of these proteins to the plasma membrane and is
required for the transforming activity of oncogenic variants of Ras, making
FTase a prime target for anticancer therapeutics. The high-resolution crystal
structure of rat FTase was recently determined, and we present here the X-ray
crystal structure of the first complex of FTase with a FPP substrate bound at
the active site. The isoprenoid moiety of FPP binds in an extended conformation
in a hydrophobic cavity of the beta subunit of the FTase enzyme, and the
diphosphate moiety binds to a positively charged cleft at the top of this cavity
near the subunit interface. The observed location of the FPP molecule is
consistent with mutagenesis data. This binary complex of FTase with FPP leads us
to suggest a "molecular ruler" hypothesis for isoprenoid substrate specificity,
where the depth of the hydrophobic binding cavity acts as a ruler discriminating
between isoprenoids of differing lengths. Although other length isoprenoids may
bind in the cavity, only the 15-carbon farnesyl moiety binds with its C1 atom in
register with a catalytic zinc ion as required for efficient transfer to the Ras
substrate.
|
|
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
J.L.Li,
P.Zhang,
Y.M.Lee,
J.Hong,
E.S.Yoo,
K.S.Bae,
and
J.H.Jung
(2011).
Oxygenated Hexylitaconates from a marine sponge-derived fungus penicillium sp.
|
| |
Chem Pharm Bull (Tokyo),
59,
120-123.
|
 |
|
|
|
|
 |
M.Andrews,
D.H.Huizinga,
and
D.N.Crowell
(2010).
The CaaX specificities of Arabidopsis protein prenyltransferases explain era1 and ggb phenotypes.
|
| |
BMC Plant Biol,
10,
118.
|
 |
|
|
|
|
 |
M.A.Hast,
S.Fletcher,
C.G.Cummings,
E.E.Pusateri,
M.A.Blaskovich,
K.Rivas,
M.H.Gelb,
W.C.Van Voorhis,
S.M.Sebti,
A.D.Hamilton,
and
L.S.Beese
(2009).
Structural basis for binding and selectivity of antimalarial and anticancer ethylenediamine inhibitors to protein farnesyltransferase.
|
| |
Chem Biol,
16,
181-192.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
A.I.Anzellotti,
and
N.P.Farrell
(2008).
Zinc metalloproteins as medicinal targets.
|
| |
Chem Soc Rev,
37,
1629-1651.
|
 |
|
|
|
|
 |
T.Subramanian,
S.Liu,
J.M.Troutman,
D.A.Andres,
and
H.P.Spielmann
(2008).
Protein farnesyltransferase-catalyzed isoprenoid transfer to peptide depends on lipid size and shape, not hydrophobicity.
|
| |
Chembiochem,
9,
2872-2882.
|
 |
|
|
|
|
 |
G.Cui,
and
K.M.Merz
(2007).
Computational studies of the farnesyltransferase ternary complex part II: the conformational activation of farnesyldiphosphate.
|
| |
Biochemistry,
46,
12375-12381.
|
 |
|
|
|
|
 |
J.Penner-Hahn
(2007).
Zinc-promoted alkyl transfer: a new role for zinc.
|
| |
Curr Opin Chem Biol,
11,
166-171.
|
 |
|
|
|
|
 |
S.F.Sousa,
P.A.Fernandes,
and
M.J.Ramos
(2007).
Theoretical studies on farnesyltransferase: the distances paradox explained.
|
| |
Proteins,
66,
205-218.
|
 |
|
|
|
|
 |
W.Xie,
C.Zhou,
and
R.H.Huang
(2007).
Structure of tRNA dimethylallyltransferase: RNA modification through a channel.
|
| |
J Mol Biol,
367,
872-881.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
B.Li,
J.P.Yu,
J.S.Brunzelle,
G.N.Moll,
W.A.van der Donk,
and
S.K.Nair
(2006).
Structure and mechanism of the lantibiotic cyclase involved in nisin biosynthesis.
|
| |
Science,
311,
1464-1467.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
F.Minutolo,
S.Bertini,
L.Betti,
R.Danesi,
G.Gervasi,
G.Giannaccini,
A.Martinelli,
A.M.Papini,
E.Peroni,
G.Placanica,
S.Rapposelli,
T.Tuccinardi,
and
M.Macchia
(2006).
Synthesis of stable analogues of geranylgeranyl diphosphate possessing a (Z,E,E)-geranylgeranyl side chain, docking analysis, and biological assays for prenyl protein transferase inhibition.
|
| |
ChemMedChem,
1,
218-224.
|
 |
|
|
|
|
 |
T.H.Chang,
R.T.Guo,
T.P.Ko,
A.H.Wang,
and
P.H.Liang
(2006).
Crystal structure of type-III geranylgeranyl pyrophosphate synthase from Saccharomyces cerevisiae and the mechanism of product chain length determination.
|
| |
J Biol Chem,
281,
14991-15000.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
G.Cui,
B.Wang,
and
K.M.Merz
(2005).
Computational studies of the farnesyltransferase ternary complex part I: substrate binding.
|
| |
Biochemistry,
44,
16513-16523.
|
 |
|
|
|
|
 |
H.Y.Sun,
T.P.Ko,
C.J.Kuo,
R.T.Guo,
C.C.Chou,
P.H.Liang,
and
A.H.Wang
(2005).
Homodimeric hexaprenyl pyrophosphate synthase from the thermoacidophilic crenarchaeon Sulfolobus solfataricus displays asymmetric subunit structures.
|
| |
J Bacteriol,
187,
8137-8148.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
N.Ferri,
R.Paoletti,
and
A.Corsini
(2005).
Lipid-modified proteins as biomarkers for cardiovascular disease: a review.
|
| |
Biomarkers,
10,
219-237.
|
 |
|
|
|
|
 |
S.F.Sousa,
P.A.Fernandes,
and
M.J.Ramos
(2005).
Farnesyltransferase--new insights into the zinc-coordination sphere paradigm: evidence for a carboxylate-shift mechanism.
|
| |
Biophys J,
88,
483-494.
|
 |
|
|
|
|
 |
W.C.Guida,
A.D.Hamilton,
J.W.Crotty,
and
S.M.Sebti
(2005).
Protein farnesyltransferase: flexible docking studies on inhibitors using computational modeling.
|
| |
J Comput Aided Mol Des,
19,
871-885.
|
 |
|
|
|
|
 |
S.Y.Chang,
T.P.Ko,
A.P.Chen,
A.H.Wang,
and
P.H.Liang
(2004).
Substrate binding mode and reaction mechanism of undecaprenyl pyrophosphate synthase deduced from crystallographic studies.
|
| |
Protein Sci,
13,
971-978.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
V.E.Ahn,
E.I.Lo,
C.K.Engel,
L.Chen,
P.M.Hwang,
L.E.Kay,
R.E.Bishop,
and
G.G.Privé
(2004).
A hydrocarbon ruler measures palmitate in the enzymatic acylation of endotoxin.
|
| |
EMBO J,
23,
2931-2941.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
J.S.Pickett,
K.E.Bowers,
and
C.A.Fierke
(2003).
Mutagenesis studies of protein farnesyltransferase implicate aspartate beta 352 as a magnesium ligand.
|
| |
J Biol Chem,
278,
51243-51250.
|
 |
|
|
|
|
 |
J.S.Taylor,
T.S.Reid,
K.L.Terry,
P.J.Casey,
and
L.S.Beese
(2003).
Structure of mammalian protein geranylgeranyltransferase type-I.
|
| |
EMBO J,
22,
5963-5974.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
O.Pylypenko,
A.Rak,
R.Reents,
A.Niculae,
V.Sidorovitch,
M.D.Cioaca,
E.Bessolitsyna,
N.H.Thomä,
H.Waldmann,
I.Schlichting,
R.S.Goody,
and
K.Alexandrov
(2003).
Structure of Rab escort protein-1 in complex with Rab geranylgeranyltransferase.
|
| |
Mol Cell,
11,
483-494.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
C.C.Huang,
C.V.Smith,
M.S.Glickman,
W.R.Jacobs,
and
J.C.Sacchettini
(2002).
Crystal structures of mycolic acid cyclopropane synthases from Mycobacterium tuberculosis.
|
| |
J Biol Chem,
277,
11559-11569.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
K.N.Cho,
and
K.I.Lee
(2002).
Chemistry and biology of Ras farnesyltransferase.
|
| |
Arch Pharm Res,
25,
759-769.
|
 |
|
|
|
|
 |
P.H.Liang,
T.P.Ko,
and
A.H.Wang
(2002).
Structure, mechanism and function of prenyltransferases.
|
| |
Eur J Biochem,
269,
3339-3354.
|
 |
|
|
|
|
 |
S.B.Long,
P.J.Casey,
and
L.S.Beese
(2002).
Reaction path of protein farnesyltransferase at atomic resolution.
|
| |
Nature,
419,
645-650.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
H.C.Schmid,
U.Oster,
J.Kögel,
S.Lenz,
and
W.Rüdiger
(2001).
Cloning and characterisation of chlorophyll synthase from Avena sativa.
|
| |
Biol Chem,
382,
903-911.
|
 |
|
|
|
|
 |
K.E.Hightower,
P.J.Casey,
and
C.A.Fierke
(2001).
Farnesylation of nonpeptidic thiol compounds by protein farnesyltransferase.
|
| |
Biochemistry,
40,
1002-1010.
|
 |
|
|
|
|
 |
S.B.Long,
P.J.Hancock,
A.M.Kral,
H.W.Hellinga,
and
L.S.Beese
(2001).
The crystal structure of human protein farnesyltransferase reveals the basis for inhibition by CaaX tetrapeptides and their mimetics.
|
| |
Proc Natl Acad Sci U S A,
98,
12948-12953.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
C.Huang,
K.E.Hightower,
and
C.A.Fierke
(2000).
Mechanistic studies of rat protein farnesyltransferase indicate an associative transition state.
|
| |
Biochemistry,
39,
2593-2602.
|
 |
|
|
|
|
 |
D.M.Cermak,
D.F.Wiemer,
K.Lewis,
and
R.J.Hohl
(2000).
2-(Acyloxy)ethylphosphonate analogues of prenyl pyrophosphates: synthesis and biological characterization.
|
| |
Bioorg Med Chem,
8,
2729-2737.
|
 |
|
|
|
|
 |
F.S.Buckner,
K.Yokoyama,
L.Nguyen,
A.Grewal,
H.Erdjument-Bromage,
P.Tempst,
C.L.Strickland,
L.Xiao,
W.C.Van Voorhis,
and
M.H.Gelb
(2000).
Cloning, heterologous expression, and distinct substrate specificity of protein farnesyltransferase from Trypanosoma brucei.
|
| |
J Biol Chem,
275,
21870-21876.
|
 |
|
|
|
|
 |
G.C.Prendergast,
and
A.Oliff
(2000).
Farnesyltransferase inhibitors: antineoplastic properties, mechanisms of action, and clinical prospects.
|
| |
Semin Cancer Biol,
10,
443-452.
|
 |
|
|
|
|
 |
H.Zhang,
M.C.Seabra,
and
J.Deisenhofer
(2000).
Crystal structure of Rab geranylgeranyltransferase at 2.0 A resolution.
|
| |
Structure,
8,
241-251.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
K.Sauer,
and
R.K.Thauer
(2000).
Methyl-coenzyme M formation in methanogenic archaea. Involvement of zinc in coenzyme M activation.
|
| |
Eur J Biochem,
267,
2498-2504.
|
 |
|
|
|
|
 |
M.J.Saderholm,
K.E.Hightower,
and
C.A.Fierke
(2000).
Role of metals in the reaction catalyzed by protein farnesyltransferase.
|
| |
Biochemistry,
39,
12398-12405.
|
 |
|
|
|
|
 |
R.A.Spence,
K.E.Hightower,
K.L.Terry,
L.S.Beese,
C.A.Fierke,
and
P.J.Casey
(2000).
Conversion of Tyr361 beta to Leu in mammalian protein farnesyltransferase impairs product release but not substrate recognition.
|
| |
Biochemistry,
39,
13651-13659.
|
 |
|
|
|
|
 |
S.B.Long,
P.J.Casey,
and
L.S.Beese
(2000).
The basis for K-Ras4B binding specificity to protein farnesyltransferase revealed by 2 A resolution ternary complex structures.
|
| |
Structure,
8,
209-222.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
S.B.Singh,
H.Jayasuriya,
K.C.Silverman,
C.A.Bonfiglio,
J.M.Williamson,
and
R.B.Lingham
(2000).
Efficient syntheses, human and yeast farnesyl-protein transferase inhibitory activities of chaetomellic acids and analogues.
|
| |
Bioorg Med Chem,
8,
571-580.
|
 |
|
|
|
|
 |
W.Yang,
J.Urano,
and
F.Tamanoi
(2000).
Protein farnesylation is critical for maintaining normal cell morphology and canavanine resistance in Schizosaccharomyces pombe.
|
| |
J Biol Chem,
275,
429-438.
|
 |
|
|
|
|
 |
Y.P.Pang,
K.Xu,
J.E.Yazal,
and
F.G.Prendergas
(2000).
Successful molecular dynamics simulation of the zinc-bound farnesyltransferase using the cationic dummy atom approach.
|
| |
Protein Sci,
9,
1857-1865.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
A.Oliff
(1999).
Farnesyltransferase inhibitors: targeting the molecular basis of cancer.
|
| |
Biochim Biophys Acta,
1423,
C19-C30.
|
 |
|
|
|
|
 |
H.Zhang,
and
N.V.Grishin
(1999).
The alpha-subunit of protein prenyltransferases is a member of the tetratricopeptide repeat family.
|
| |
Protein Sci,
8,
1658-1667.
|
 |
|
|
|
|
 |
J.K.Buolamwini
(1999).
Novel anticancer drug discovery.
|
| |
Curr Opin Chem Biol,
3,
500-509.
|
 |
|
|
|
|
 |
K.Del Villar,
J.Urano,
L.Guo,
and
F.Tamanoi
(1999).
A mutant form of human protein farnesyltransferase exhibits increased resistance to farnesyltransferase inhibitors.
|
| |
J Biol Chem,
274,
27010-27017.
|
 |
|
|
|
|
 |
K.E.Hightower,
and
C.A.Fierke
(1999).
Zinc-catalyzed sulfur alkyation:insights from protein farnesyltransferase.
|
| |
Curr Opin Chem Biol,
3,
176-181.
|
 |
|
|
|
|
 |
K.Wang,
and
S.Ohnuma
(1999).
Chain-length determination mechanism of isoprenyl diphosphate synthases and implications for molecular evolution.
|
| |
Trends Biochem Sci,
24,
445-451.
|
 |
|
|
|
|
 |
M.Scarsi,
N.Majeux,
and
A.Caflisch
(1999).
Hydrophobicity at the surface of proteins.
|
| |
Proteins,
37,
565-575.
|
 |
|
|
|
|
 |
Z.S.Zhou,
K.Peariso,
J.E.Penner-Hahn,
and
R.G.Matthews
(1999).
Identification of the zinc ligands in cobalamin-independent methionine synthase (MetE) from Escherichia coli.
|
| |
Biochemistry,
38,
15915-15926.
|
 |
|
|
|
|
 |
C.L.Strickland,
W.T.Windsor,
R.Syto,
L.Wang,
R.Bond,
Z.Wu,
J.Schwartz,
H.V.Le,
L.S.Beese,
and
P.C.Weber
(1998).
Crystal structure of farnesyl protein transferase complexed with a CaaX peptide and farnesyl diphosphate analogue.
|
| |
Biochemistry,
37,
16601-16611.
|
 |
|
PDB code:
|
 |
|
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
codes are
shown on the right.
|
');
}
}
 |